Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
1,385
-301
-18% -$479K 0.62% 22
2026
Q1
$2.23M Sell
1,686
-375
-18% -$514K 0.51% 24
2025
Q4
$2.2M Sell
2,061
-256
-11% -$267K 0.55% 27
2025
Q3
$2.24M Buy
2,317
+4
+0.2% +$3.14K 0.58% 24
2025
Q2
$1.85M Sell
2,313
-11
-0.5% -$7.89K 0.51% 33
2025
Q1
$1.54M Sell
2,324
-68
-3% -$49.5K 0.43% 35
2024
Q4
$1.66M Buy
2,392
+195
+9% +$140K 0.46% 34
2024
Q3
$1.83M Buy
2,197
+390
+22% +$349K 0.5% 31
2024
Q2
$1.85M Sell
1,807
-27
-1% -$26K 0.52% 27
2024
Q1
$1.78M Sell
1,834
-237
-11% -$210K 0.5% 30
2023
Q4
$1.57M Buy
2,071
+6
+0.3% +$3.96K 0.48% 35
2023
Q3
$1.22M Buy
2,065
+543
+36% +$361K 0.37% 47
2023
Q2
$1.1M Buy
+1,522
New +$1.03M 0.34% 61

Other funds holding ASML

Doliver Advisors's ASML Position: Q2 2026 in Review

Doliver Advisors reduced its ASML (ASML) stake by 18% in Q2 2026, selling an estimated $479K and leaving 1,385 shares worth $2.76M. The position accounts for 0.62% of the portfolio, ranked #22.

Doliver Advisors first reported a position in ASML in Q2 2023 and has held it in 13 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Doliver Advisors held 1,385 shares of ASML worth $2.76M as of Q2 2026.
  • Doliver Advisors sold 301 ASML shares in Q2 2026, an estimated $479K.
  • ASML made up 0.62% of Doliver Advisors's portfolio in Q2 2026, its #22 holding.
  • Doliver Advisors first reported a position in ASML in Q2 2023 and has held it in 13 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.